Skip to main content
. Author manuscript; available in PMC: 2013 Nov 3.
Published in final edited form as: Steroids. 2010 Apr 2;75(10):10.1016/j.steroids.2010.03.008. doi: 10.1016/j.steroids.2010.03.008

Fig. 7. [3H] leucine incorporation in C2C12 myotubes pretreated with G-protein inhibitor, PTX.

Fig. 7

Differentiated myotubes were pretreated with the G protein inhibitor, 1 μg/ml PTX, or vehicle for 1 h before treatment with 1 μM 20HE, 100 ng/ml IGF-1, or vehicle. DPM were normalized by total protein. Data represent the mean values ± S.E.M. of three experiments. a indicates p < 0.05 compared with control and b indicates p < 0.05 compared with PTX treatment alone (One way ANOVA/Bonferroni).